Viewing Study NCT04739761


Ignite Creation Date: 2025-12-24 @ 12:44 PM
Ignite Modification Date: 2026-01-03 @ 5:54 PM
Study NCT ID: NCT04739761
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-10
First Post: 2021-01-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-06-22
Start Date Type: ACTUAL
Primary Completion Date: 2024-02-08
Primary Completion Date Type: ACTUAL
Completion Date: 2026-02-03
Completion Date Type: ESTIMATED
First Submit Date: 2021-01-20
First Submit QC Date: None
Study First Post Date: 2021-02-05
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-02-06
Results First Submit QC Date: None
Results First Post Date: 2025-05-16
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-09
Last Update Post Date: 2025-09-10
Last Update Post Date Type: ESTIMATED